GSK926 (compound 3) is a selective histone lysine methyltransferase EZH2 inhibitor ( IC 50 =0.02 μM; K i =7.9 nM), with SAM-competitive and cell-active properties. GSK926 can be used in cancer research.
Products | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histone Methyltransferase
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。